Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179477 · ClinicalTrials.gov registry record
QuickFlex Micro Left Ventricular Lead Post Approval Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,930
- Enrollment target
NCT01179477 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,930 participants.
The verdict
NCT01179477 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,930 participants
- Enrollment target
Study Summary
The purpose of this multicenter post-approval study is to evaluate the acute and chronic performance of the QuickFlex® μ 1258T left ventricular (LV) lead.
Interventions
- DEVICE Implantation of a QuickFlex® μ Model 1258T LV Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,930 participants |
| Start Date | 2010-09 |
| Est. Completion | 2017-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01179477
The ClinicalTrials.gov registry entry for NCT01179477 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,930 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantation of a QuickFlex® μ Model 1258T LV Lead is the first listed.
NCT01179477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01179477 about?
NCT01179477 is a clinical study titled "QuickFlex Micro Left Ventricular Lead Post Approval Study". The purpose of this multicenter post-approval study is to evaluate the acute and chronic performance of the QuickFlex® μ 1258T left ventricular (LV) lead.
What is the current status of trial NCT01179477?
This trial is currently completed. The enrollment target is 1,930 participants. The study started on 2010-09. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01179477?
The interventions under investigation include: Implantation of a QuickFlex® μ Model 1258T LV Lead (DEVICE).
Who is sponsoring clinical trial NCT01179477?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.